Coumaric Acid

Coumaric Acid

SCHEMBL7871865

Cl.O=C(O)C=Cc1ccc(O)cc1

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Coumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 known ✓ P03372 5/20 0.95
CA2 known ✓ P00918 3/20 0.95
ESR2 known ✓ Q92731 3/20 0.95
DPP4 known ✓ P27487 2/20 0.95
HSD11B1 known ✓ P28845 1/20 0.68
HDAC3 known ✓ O15379 2/20 0.64
HDAC4 known ✓ P56524 2/20 0.64
HDAC1 known ✓ Q13547 2/20 0.64
HDAC7 known ✓ Q8WUI4 2/20 0.64
HDAC2 known ✓ Q92769 2/20 0.64
HDAC10 known ✓ Q969S8 2/20 0.64
HDAC11 known ✓ Q96DB2 2/20 0.64
HDAC8 known ✓ Q9BY41 2/20 0.64
HDAC6 known ✓ Q9UBN7 2/20 0.64
HDAC9 known ✓ Q9UKV0 2/20 0.64
HDAC5 known ✓ Q9UQL6 2/20 0.64
MAOB known ✓ P27338 1/20 0.63
PTGS2 known ✓ P35354 1/20 0.63
TTR known ✓ P02766 1/20 0.59
MMP1 known ✓ P03956 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Coumaric Acid SCHEMBL39106 0.98 ESR1 (1.00) ESR1TYRAKR1B10AKR1B1CA12
Coumaric Acid SCHEMBL6333097 0.98 ESR1 (1.00) ESR1TYRAKR1B10AKR1B1CA12
Coumaric Acid SCHEMBL20702657 0.98 ESR1 (1.00) ESR1TYRAKR1B10AKR1B1CA12
Coumaric Acid SCHEMBL6333102 0.98 ESR1 (1.00) ESR1TYRAKR1B10AKR1B1CA12
Coumaric Acid SCHEMBL43601 0.98 ESR1 (1.00) ESR1TYRAKR1B10AKR1B1CA12
Coumaric Acid SCHEMBL434720 0.98 ESR1 (1.00) ESR1TYRAKR1B10AKR1B1CA12
Coumaric Acid SCHEMBL7040450 0.95 ESR1 (0.95) ESR1TYRAKR1B10AKR1B1CA12
Coumaric Acid SCHEMBL1221500 0.95 ESR1 (0.95) ESR1TYRAKR1B10AKR1B1CA12
Coumaric Acid SCHEMBL6328280 0.95 ESR1 (0.95) ESR1TYRAKR1B10AKR1B1CA12
Coumaric Acid SCHEMBL8377539 0.95 ESR1 (0.95) ESR1TYRAKR1B10AKR1B1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101591311-A 1-(3-phenyl acryloyl) bridged piperazine derivatives and preparation method thereof UNIV HEBEI TECHNOLOGY (CN) 2009-12-02 CN claimed
CN-101412668-A 3-acryloyl chloride derivative and preparation thereof UNIV HEBEI TECHNOLOGY (CN) 2009-04-22 CN claimed
CN-102653539-B Compound for resisting platelet aggregation and medicament combination thereof QIN YINLIN 2014-09-17 CN disclosed
CN-101591311-A 1-(3-phenyl acryloyl) bridged piperazine derivatives and preparation method thereof UNIV HEBEI TECHNOLOGY (CN) 2009-12-02 CN disclosed
CN-101412668-A 3-acryloyl chloride derivative and preparation thereof UNIV HEBEI TECHNOLOGY (CN) 2009-04-22 CN disclosed
EP-0702260-B1 Compensator for a liquid crystal display NIPPON MITSUBISHI OIL CORP (JP) 2001-11-21 EP disclosed
EP-0659796-B1 Liquid crystalline polyesters NIPPON OIL CO LTD (JP) 1999-03-17 EP disclosed
US-5599478-A Compensator for a liquid crystal display NIPPON OIL COMPANY, LIMITED (JP) 1997-02-04 US disclosed
EP-0702260-A1 Compensator for a liquid crystal display NIPPON OIL CO. LTD. (JP) 1996-03-20 EP disclosed
US-5432249-A Liquid crystalline polyesters NIPPON OIL COMPANY, LIMITED (JP) 1995-07-11 US disclosed
EP-0659796-A2 Liquid crystalline polyesters NIPPON OIL COMPANY, LIMITED (JP) 1995-06-28 EP disclosed